|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 25 Massachusetts Avenue, NW |
Address2 | Suite 610 |
City | Washingon |
State | DC |
Zip Code | 20001-1430 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Schaumburg |
State | IL |
Zip Code | 60173 |
Country | USA |
|
5. Senate ID# 10445-12
|
||||||||
|
6. House ID# 338760000
|
TYPE OF REPORT | 8. Year | 2019 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: MS. KATHERINE O. ORRICO |
Date | 1/21/2020 6:36:04 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
S. 348, Resident Physician Shortage Reduction Act, to provide Medicare funding for additional residency training slots
H.R. 1763, Resident Physician Shortage Reduction Act, to provide Medicare funding for additional residency training slots
H.R.1865, the Further Consolidated Appropriations Act, 2020, work geographic practice cost index (GPCI) floor, funding for the Patient-Centered Outcomes Research Institute (PCORI) for 10 years
H.R.3107, Improving Seniors Timely Access to Care Act, to establish requirements with respect to the use of prior authorization under Medicare Advantage plans, and for other purposes
No bill: Repealing/modifying Medicare's Appropriate Use Criteria Program for Advanced Diagnostic Imaging
No bill: Providing positive Medicare physician payment updates and extending bonus payments for Advanced-Alternative Payment Models and Merit-based Incentive Payment System high performers
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Katherine |
Orrico |
|
|
|
Adrienne |
Mortimer |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
S.1350, Good Samaritan Health Professionals Act, A bill to amend the Public Health Service Act to limit the liability of health care professionals who volunteer to provide health care services in response to a disaster
S.1531, STOP Surprise Medical Bills Act, To amend the Public Health Service Act to provide protections for health insurance consumers from surprise billing
S, 1895, Lower Health Care Costs Act, to lower health care costs
H.R.1865, the Further Consolidated Appropriations Act, 2020, surprise medical bills, funding for firearm injury and mortality prevention research, funding for sports- and recreation-related concussions, funding for Childrens Hospitals Graduate Medical Education
H.R.2279, Safe Step Act, to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide an exceptions process for any medication step therapy protocol
H.R.3502, Protecting People from Surprise Medical Bills Act, To protect health care consumers from surprise billing practices
H.R.3630, No Surprises Act, To protect health care consumers from surprise billing practices, and for other purposes
HR 3656, Accessible Care by Curbing Excessive lawSuitS (ACCESS) Act, comprehensive medical liability reform
No Bill: Reintroduction of the Good Samaritan Health Professionals Act, to amend the Public Health Service Act to limit the liability of health care professionals who volunteer to provide health care services in response to a disaster
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Katherine |
Orrico |
|
|
|
Adrienne |
Mortimer |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
S. 692, Protect Medical Innovation Act, to repeal the excise tax on medical devices
H.R.1865, the Further Consolidated Appropriations Act, 2020, repeal medical device excise tax, repeal ACA Cadillac tax
H.R. 2207, the Protect Medical Innovation Act of 2019, to amend the Internal Revenue Code of 1986 to repeal the excise tax on medical devices
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Katherine |
Orrico |
|
|
|
Adrienne |
Mortimer |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R.1865, the Further Consolidated Appropriations Act, 2020, funding for the National Institutes of Health
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Katherine |
Orrico |
|
|
|
Adrienne |
Mortimer |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |